Increasing Demand for Nasal Implants to Augment the Absorbable Nasal Implant Devices Market Growth
Absorbable nasal implant devices are used to support both lower and upper lateral cartilage in the nose, strengthening the nasal wall such as polymer grafts and traditional cartilage. Such implants are used to treat nasal obstruction and allow the patient to breathe better and sleep. Nasal blockage or obstruction can be caused by several factors, such as enlarged turbinates, septal deviation, and weakened lower or/and upper lateral nasal cartilage, leading to vestibular stenosis (nasal valve collapse). Symptoms include congestion, stuffiness, or an inability to breathe through one or both nostrils.
Nasal valve collapse is a term that refers to any weakness
or further narrowing of the nasal valve. Absorbable nasal implant devices improve
breathing and support the nasal cartilage. These nasal implants are generally
preferred for those who have undergone a rhinoplasty because of the possibility
of an extremely narrow-looking nose. Absorbable nasal implant devices are
important for patients where a standard treatment procedure for turbinates and
septum are not enough.
Market Dynamics:
Increasing demand for nasal implant devices and the increasing
adoption of advanced nasal implants by physicians is expected to propel the
growth of the absorbable nasal implant devices market. For instance, in 2018,
Intersect ENT announced U.S. commercial availability of the SINUVA (mometasone
furoate) Sinus Implant, a new approach to treating nasal polyp disease in adult
patients who have had previous sinus surgery.
Moreover, increasing adoption of better health care
facilities, large patient pool, and increasing awareness about advanced nasal
reconstruction procedures is expected to augment the growth of the absorbable
nasal implant devices market. However, subconscious awareness about implant
creating discomfort, mild pain, or irritation and stringent regulatory guidelines
are expected to hamper the growth of the absorbable nasal implant market.
North America is expected to witness substantial growth of
the absorbable nasal implant devices market due to increasing number of nasal
obstruction cases in the region. For instance, around 3 million people in the
United States visit a physician for nasal obstruction and 1 million procedures
are performed to alleviate the symptoms.
Competitive Analysis:
Key players operating in the absorbable nasal implant
devices market are Stryker Corporation, Pfizer, Inc., Acclarent, Inc., ArthroCare
Corp., Smith & Nephew, Inc., Mentor Worldwide LLC, Intersect ENT, Inc., and
Spirox, Inc., among others.
In June 2019, Stryker announced that more than 33,000 nasal
valve collapse (NVC) patients have been treated with its LATERA absorbable
nasal implant. LATERA is used to support the lateral nasal cartilage and
address the symptoms of NVC, helping patients breathe better.
Comments
Post a Comment